Joseph K Oppong
Overview
Explore the profile of Joseph K Oppong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Madorsky Rowdo F, Martini R, Ackermann S, Tang C, Tranquille M, Irizarry A, et al.
Cancer Res
. 2025 Feb;
85(3):551-566.
PMID: 39891928
Precision medicine approaches to cancer treatment aim to exploit genomic alterations that are specific to individual patients to tailor therapeutic strategies. Yet, some targetable genes and pathways are essential for...
2.
Madorsky Rowdo F, Xiao G, Khramtsova G, Nguyen J, Martini R, Stonaker B, et al.
Cancer Lett
. 2024 Jan;
584:216608.
PMID: 38199587
Poly (ADP-ribose) polymerase inhibitors (PARPi) are used for patients with BRCA1/2 mutations, but patients with other mutations may benefit from PARPi treatment. Another mutation that is present in more cancers...
3.
Madorsky Rowdo F, Xiao G, Khramtsova G, Nguyen J, Olopade O, Martini R, et al.
bioRxiv
. 2023 Dec;
PMID: 38076873
Poly (ADP-ribose) polymerase inhibitors (PARPi) are used for patients with mutations, but patients with other mutations may benefit from PARPi treatment. Another mutation that is present in more cancers than...
4.
Martini R, Delpe P, Chu T, Arora K, Lord B, Verma A, et al.
Cancer Discov
. 2022 Sep;
12(11):2530-2551.
PMID: 36121736
Significance: Our comprehensive ancestry quantification process revealed that ancestry-associated gene expression profiles in TNBC include population-level distinctions in immunologic landscapes. These differences may explain some differences in race-group clinical outcomes....
5.
Martini R, Chen Y, Jenkins B, Elhussin I, Cheng E, Hoda S, et al.
Sci Rep
. 2021 Apr;
11(1):9247.
PMID: 33927264
Large-scale efforts to identify breast cancer (BC) risk alleles have historically taken place among women of European ancestry. Recently, there are new efforts to verify if these alleles increase risk...
6.
Jiagge E, Ulintz P, Wong S, McDermott S, Fossi S, Suhan T, et al.
Breast Cancer Res Treat
. 2021 Feb;
186(2):391-401.
PMID: 33576900
Purpose: Triple-negative breast cancer (TNBC) is an aggressive subtype most prevalent among women of Western Sub-Saharan African ancestry. It accounts for 15-25% of African American (AA) breast cancers (BC) and...
7.
Newman L, Jenkins B, Chen Y, Oppong J, Adjei E, Jibril A, et al.
Ann Surg
. 2019 Jul;
270(3):484-492.
PMID: 31356281
Objective: To investigate subtype-specific risk of germline alleles associated with triple negative breast cancer (TNBC) in African ancestry populations. Background: Breast cancer (BC) mortality is higher in African American (AA)...
8.
Thomas A, Kidwell K, Oppong J, Adjei E, Osei-Bonsu E, Boahene A, et al.
J Glob Oncol
. 2017 Dec;
3(6):765-772.
PMID: 29244986
Purpose Breast cancer, the most common cancer worldwide, is the leading cause of cancer mortality in Ghanaian women. Previous studies find Ghanaian women are diagnosed at a younger age and...
9.
Jiagge E, Bensenhaver J, Oppong J, Awuah B, Newman L
Ann Surg Oncol
. 2015 Jan;
22(3):734-40.
PMID: 25582742
Background: Disparities in breast cancer incidence and outcome between African American and white American women are multifactorial in etiology. The increased frequency of triple-negative breast cancers (TNBC) in African American...
10.
Laryea D, Awuah B, Amoako Y, Osei-Bonsu E, Dogbe J, Larsen-Reindorf R, et al.
BMC Cancer
. 2014 Jun;
14:362.
PMID: 24884730
Background: Data on cancers is a challenge in most developing countries. Population-based cancer registries are also not common in developing countries despite the usefulness of such registries in informing cancer...